Evofosfamide (development code TH-302) is an investigational new drug that is being evaluated for the treatment of multiple tumor types, including pancreatic cancer, soft tissue sarcoma, and multiple myeloma, often in combination with other therapies.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.